Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45 | 119 | 36 | 3 | 1 |
| Receivables | N/A | N/A | N/A | N/A | 5 |
| Inventories | N/A | N/A | N/A | N/A | 7 |
| TOTAL | $45 | $119 | $36 | $3 | $13 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 673 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $673 |
| Total Assets | $45 | $119 | $36 | $3 | $686 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 69 | 31 | 34 | 53 | 37 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 29 |
| Other current liabilities | N/A | N/A | N/A | N/A | 5 |
| TOTAL | $702 | $774 | $262 | $53 | $150 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $702 | $774 | $262 | $53 | $150 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,154 | 85,104 | 85,104 | 85,104 | 110,436 |
| Common Shares | 85 | 85 | 85 | 85 | 110 |
| Retained earnings | -705 | -574 | -383 | -135 | -14,347 |
| TOTAL | $-657 | $-655 | $-225 | $-50 | $536 |
| Total Liabilities And Equity | $45 | $119 | $36 | $3 | $686 |